All USA & Canada articles
-
News
Broader antibiotic use could change the course of cholera outbreaks, research suggests
Disease modeling research suggests that, for some cholera outbreaks, prescribing antibiotics more aggressively could slow or stop the spread of the disease and even reduce the likelihood of antibiotic resistance.
-
News
Fungi dwelling on human skin may provide new antibiotics
Researchers have uncovered a molecule produced by yeast living on human skin that showed potent antimicrobial properties against a pathogen responsible for a half-million hospitalizations annually in the United States.
-
News
Now is the time to strengthen infection prevention and control (IPC) programs in healthcare facilities
A joint position paper urges United States healthcare facilities to elevate the standards and effectiveness of their Infection Prevention and Control (IPC) programs.
-
News
How math helps to protect crops from invasive disease
New research demonstrates how mathematical modeling can predict outbreaks of toxic fungi in Texas corn crops—offering a potential lifeline to farmers facing billions in harvest losses.
-
News
Measles may be making a comeback in the US, research finds
If immunization rates drop further over a prolonged period of time, measles and even other wiped-out diseases — such as rubella and polio — could one day make a comeback in the United States, according to a new study.
-
News
Bacteria’s mysterious viruses can fan flames of antibiotic damage, according to new model
Researchers built a model that allows them to diminish phage communities from a mouse gut microbiome — and then bring them back — without affecting the bacteria. A test run found evidence that phages may increase gut bacteria’s sensitivity to antibiotics.
-
News
Global virus network issues urgent call to action to mitigate the rising threat of H5N1 avian influenza
The Global Virus Network (GVN) has issued a call-to-action, calling on world governments to address the threat of H5N1 avian influenza by enhancing surveillance, implementing biosecurity measures, and preparing for potential human-to-human transmission.
-
News
Updated recommendations to prevent infections through effective sterilization and high-level disinfection of reusable medical devices
New comprehensive guidance has been released in the US to help healthcare facilities prevent the transmission of infections through improved practices in sterilization and high-level disinfection (HLD) of reusable medical devices.
-
News
Tick researchers identify new strain of rickettsia bacteria that causes spotted fever infections in humans
In a residential backyard in Maine, researchers stumbled upon a surprise finding: rabbit ticks harboring a new type of bacteria related to a group of pathogens that can cause sometimes life-threatening spotted fever rickettsioses (SFR) infections in humans.
-
News
Study identifies how malaria can lead to childhood cancer
New data has uncovered the role of Plasmodium falciparum infection (malaria) in the development of Burkitt lymphoma (BL), the most common childhood cancer in equatorial Africa and New Guinea.
-
News
Hospital-based outbreak detection system saves lives
An infectious diseases detection platform has proved over a two-year trial that it stops outbreaks, saves lives and cuts costs. The results make the case for adoption in hospitals nationwide and the development of a national early outbreak detection database.
-
News
Success of agile COVID-19 pan-Canadian research network highlights how to tackle future pandemics
The operations of CoVaRR-Net, a national interdisciplinary research network initiated to study COVID-19 variants and enhance Canada’s preparedness for future pandemics, have concluded following the expiration of funding.
-
News
Atomic imaging and AI offer new insights into motion of parasite behind sleeping sickness
Researchers applied leading-edge atomic imaging and AI-driven modeling to create the most detailed 3D map yet of the flagellum on Trypanosoma brucei, which causes sleeping sickness.
-
News
Transatlantic collaboration to develop therapeutic for Crimean-Congo Hemorrhagic Fever
A new transatlantic collaboration will look to develop an affordable and accessible monoclonal antibody therapeutic for Crimean-Congo Hemorrhagic Fever Virus (CCHFV), which could treat and protect thousands of people globally.
-
News
Infectious disease surveillance platform BEACON launches as a new open-source global resource
The Biothreats Emergence, Analysis and Communications Network (BEACON), an open-source infectious diseases monitoring tool powered by AI and human experts, has been launched.
-
News
Psilocibin or ‘magic mushroom’ use in US increased among all age groups since decriminalization in 2019
The prevalence of psilocybin use in the US has increased across all age groups between 2014 and 2023, with those with mental or physical comorbidities among the most common users.
-
News
Study: Experimental bird flu vaccine excels in animal models
A vaccine has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. It focuses on the H5N1 variant known as 2.3.4.4b, which has caused widespread outbreaks in wild birds and poultry.
-
News
Frequent use of antibiotics in infants and young children may increase risk for asthma, allergies and other conditions
Researchers have found that repeated antibiotic use before age 2 is associated with a higher risk for asthma, food allergies and hay fever later in life. These findings also applied to siblings who had different experiences with antibiotics.
-
News
The very first structural images of a tuberculosis-fighting virus
Scientists have used advanced imaging techniques to provide a detailed look at how a tiny virus, known as a phage, invades Mycobacteria. The research could pave the way toward phage-based treatments for antibiotic-resistant mycobacteria.
-
News
Dr. Sabine Ehrt named Chair of the Department of Microbiology and Immunology at Weill Cornell Medicine
Dr. Sabine Ehrt, an internationally renowned leader in tuberculosis research, has been appointed chair of the Department of Microbiology and Immunology at Weill Cornell Medicine.